Clinical Trial

Non-contact Proactive Remote Monitoring of COPD Exacerbations

Study acronym: DetectEx
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 24, 2025 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to determine if a COPD exacerbation can be detected early in its onset. The main questions it aims to answer are: * Can an exacerbation be detected before the person recognizes they are unwell? * What are the biological signals which provide the best indication of decompensation? * How does this indication of decompensation compare to a daily CAT? Participants will be asked to place a device, DistaSense, on top of their mattress and then sleep as normal. In addition, they will be asked to complete a daily CAT.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-10-26; most recent amendment 2025-03-19.
Status change: Not Yet Recruiting → Recruiting 2025-03-19
Trial Details
NCT Number NCT05598983
Lead Sponsor Life Detection Technologies
Collaborators: Royal Free Hospital NHS Foundation Trust
Conditions COPD Exacerbation
Enrollment 75 participants
Start Date 2023-05-15
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2025-03-24